Research Article - (2013) Volume 1, Issue 3

Haematological Profile of HIV Infected Patients with Opportunistic Respiratory Mycoses in Relation to Immune Status–A Hospital Based Cohort from Calabar, Nigeria

Ofonime M Ogba1*, Lydia N Abia-Bassey2, James Epoke2, Baki I Mandor1, Josephine Akpotuzor2, Godwin Iwatt3 and Ikwo Ibanga4
1Department of Microbiology/Parasitology, University of Calabar Teaching Hospital, Calabar, Nigeria
2Department of Medical Laboratory Science, University of Calabar, Nigeria
3Department of Microbiology, University of Calabar, Nigeria
4Department of Haematology, University of Calabar, Nigeria
*Corresponding Author: Ofonime M Ogba, Department of Microbiology/ Parasitology, University of Calabar Teaching Hospital, Calabar, Nigeria, Tel: +2348035404728 Email:

Abstract

 Objectives: To study the spectrum of hematological manifestations and evaluate the relationship between various hematological manifestations and CD4 cell count among opportunistic respiratory mycoses positive adult HIV patients in Calabar, Nigeria. Materials and methods: The hematological and mycological profiles of the 272 HIV infected patients with respiratory symptoms attending the Anti Retroviral (ARV) and Infectious disease clinics in Calabar, from May 2009 to July 2010 were recorded. The relationship between hematological manifestations and CD4 counts among the respiratory mycoses positive subjects were analyzed. Results: The most common haematological abnormality was anaemia with 129(47.2%) subjects affected. Also among the mycoses positive subjects’ anaemia was more prevalent in females 32(43.8%) than males 26(46.4%), but there was no relationship between mycoses and anaemia among subjects (X2=4.3, p=0.6). All subjects infected with fungal pathogens had CD4 counts below 200 cells/μl of blood. Conclusion: Subjects with mycoses are more likely to develop haematological abnormalities like anaemia, neutropenia and lymphopenia due to further suppression of their immune status. This suggests that respiratory mycoses may affect haematological parameters of patients especially the lymphocytes and CD4 counts.

Keywords: HIV; Immune system; Haematology; Mycology

Introduction

Hematological abnormalities are among the most common complications of HIV. These involve all lineages of blood cells [1]. Acquired Immune Deficiency Syndrome (AIDS) is caused by the Human Immunodeficiency Virus (HIV) and is characterized by progressive damage to the body’s immune system which results in a number of opportunistic infections, immunological and haematological complications [2]. Fungal infections are common complications of HIV/AIDS and pulmonary complications remain a major cause of both morbidity and mortality in immunocompromised patients [3].

The common opportunistic respiratory fungal pathogens include; Candida species, Aspergillus species, Mucor species, Cryptococcus neoformans and Pneumocystis carinii. These tend to cause pneumonia in patients with acquired defects in their defenses and are ubiquitous in nature [4,5]. The organims that causes human pneumocystosis is now named Pneumocystis jiroveci in honor of the Czech parasitologist Otto Jirovec. The organism is now considered a fungus, based on nucelic acid and biochemical analysis [6].

Haematological complications among HIV patients are generally marked with cytopenias such as anaemia, neutropenia, lymphopenia and thrombocytopenia [7,8]. The incidence and severity of the cytopenia generally correlate to the stage of the disease with anaemia being the most commonly encountered haematologic abnormality and a significant predictor of progression to AIDS or death [9,10]. The mechanism underlying these abnormalities is still obscure. A specific diagnosis of the cause and mechanism must be sought because specific treatment may be needed for its correction [1]. The main immunological complication and hallmark of HIV infection is cellular CD4 T-lymphocyte depletion for which various mechanisms have been suggested [11]. There are major differences in the spectrum of opportunistic infections in Nigeria and the West [3], but data on the hematological manifestations among pulmonary mycoses positive patients is sparse in Nigeria.

Study Objectives

To determine the spectrum of hematological manifestations and evaluate the relationship between various hematological manifestations and CD4 cell count among respiratory mycoses positive adult HIV patients in Calabar, Nigeria. This study was conducted since there is no information from the South-South geopolitical zone in Nigeria regarding the hematological manifestations among patients with respiratory mycoses and the probable interpretation of the same in this population.

Materials and Methods

Study population and design

During the 14 months prospective study which lasted from May 2009 to July 2010, 272 HIV infected patients with respiratory symptoms who were able to produce sputum were enrolled to determine if they had fungal infections and to evaluate their hematologic manifestations. Patients were recruited after obtaining their informed consent from the outpatient department, wards and the Anti-Retroviral Treatment Clinic of University of Calabar Teaching Hospital and Lawrence Henshaw Hospital, Calabar. These are tertiary care hospitals with catchment areas to neighboring Local Government Areas. Ethical approval was also obtained from the ethical committee of University of Calabar Teaching Hospital. All patients were evaluated by a pre-designed protocol covering the biodata, history, marital status, presenting complaints and physical examination. Patients were excluded if they refused to be part of the study, were unable to produce sputum or were less than 16 years of age.

Sample collection and processing

Five milliliter of venous blood was collected from each patient for haematological and immunological (CD4 estimation) analysis. Also two repeated samples of early morning expectorate sputum was collected from all the subjects enrolled in the study under universal aseptic precautions in suitable sterile containers [12].

Haematological and immunological assay

Absolute counts of CD4 lymphocytes were assayed using the BD FACS count system (Becton Dickenson and Company, California, USA). Haematological parameters: haemoglobin (Hb), haematocrit (PCV), Mean Cell Haemoglobin Concentration (MCHC), White Blood Cell Count (WBC), Lymphocyte Count (LC), was determined using the Sysmex automated blood analyzer.

Anaemia was defined as haemoglobin <11.2 g/dl (women) and 12.1 g/dl (men). The various degrees of anaemia were classified using haemoglobin (Hbg/dl) (females/males) values of <11.2/12.1 g/dl: mild, <9.0/10.4 g/dl: moderate and <8.0/9.3 g/dl: severe anaemia respectively. Leucopenia was defined as total WBC count less than 2000 cells/μl. Neutropenia was defined as a neutrophil count <40%. Lymphopenia was considered when lymphocyte count was <30%. Thrombocytopenia was defined as total platelet count of <100×103/μl [13,14]. The critical value of CD4 counts among HIV patients is 350 cell/μl [15].

Mycological assay

Standard mycological techniques were used for the isolation, detection and identification of the fungal pathogens. Direct microscopy of sputum samples was carried out by the use of 10% KOH mount, India ink preparation, modified Gomori’s methenamine silver stained (Grocott’s stain) and wherever indicated Gram stain were prepared for each of the samples. Sputum samples were inoculated on Sabouraud Dextrose Agar (SDA) with and without chloramphenicol (16 μgml-1) in duplicates (incubated at 37°C and 25°C) alongside caffeic agar plates incubated at 37°C. Cultures were examined every other day for growth up to 4 weeks before discarding as negative [16,17]. Identification of isolates was based on gross morphology, microscopy and biochemical features. [18,19]. Serological tests were performed on the serum collected from the patients for Cryptococcus neoformans antigen detection, using the cryptococcal antigen latex agglutination system (Crypto-LA Test, USA) according to manufacturer’s instruction [20-22].

Mycoses positive subjects were those with respiratory tract disease caused by fungi. This was determined by repeated isolation of the fungi from two consecutive sputum samples which rules out colonization or sputum contamination of samples with oropharyngeal flora. Pneumocystis carinii infections were diagnosed by microscopy. To rule out the possibility of oropharyngeal colonization by Candida species, a common feature among the HIV patients, those cases with plenty of pseudohyphae on smear examination are considered as significant pathogens [20].

Data analysis

Data were analyzed using Epi Info 2000 (CDC, Atlanta, Georgia, USA) statistical software and the Microsoft Excel Analysis ToolPak. Descriptive statistics was expressed as mean ± SD. Frequencies (prevalence, etc.) were calculated for categorical variables. Comparison of means were done by the student’s t test. Interactions between specific categorical clinical variables were tested for significance using the χ2 test. A p value of 0.05 was considered statistically significant.

Results

Out of the 272 HIV positive subjects investigated for mycoses, 86 (31.6%) were positive of whom 55 (64.0%) were females and 31 (36.0%) were males. Patients with mycoses were relatively younger (33.6 ± 10.6 years) than those without mycoses (35.2 ± 11.5 years) but there was no statistically significant relationship between age and mycoses (p=0.2).

Out of the 272 HIV positive subjects, 129 (47.4%) had anaemia, 50(18.4%) were mycoses positive while 79 (29.0%) were mycoses negative, but there was no statistically significant relationship between anaemia and mycoses (χ2=7.07, p=0.13) (Table 1).

Mycoses status (n=272) No of patients with Anaemia(%)
Positive 50(18.3)
Negative 79(29.0)
Total 129(47.4)

Table 1: Distribution of anaemia among HIV positive subjects with and without mycsoses.

Out of the 50(58.1%) mycoses positive patients with various degrees of anaemia, 20(36.4%) females had mild anaemia while only 5(9.5%) had severe anaemia. Also 6 (19.4%) males had mild anaemia while 3 (9.7%) had severe anaemia. Anaemia was more prevalent in females 32 (37.2%) than males 18(20.9%), but there was no relationship between mycoses and anaemia among the subjects (χ2=4.7, p=0.31) (Table 2).

Gender Anaemic status
Mild Moderate Severe Total (n=86)
Female (n=55) 20(36.4%) 7(12.7%) 5(9.5%) 32(37.2%)
Male (n=31) 6(19.4%) 9(29.0%) 3(9.7%) 18(20.9%)
Total 26 16 8 50(58.1%)

Normal values of Hbg/dl were 13.5/15.0 g/dl Female/Male

Table 2: Distribution of Anaemia among HIV positive subjects with mycoses.

Anaemia 79 (42.5%), leucopenia 15 (8.1%) and neutropenia 34 (18.3%) were more prevalent among the mycoses negative subjects but there was no statistically significant relationship with mycoses (p>0.05). On the other hand, lymphopenia was more prevalent amongst the mycoses positive subjects 39 (45.3%) and there was a statistically significant relationship between lymphopenia and mysoses (χ2=33.2, p=0.00) (Table 3). Most of the subjects with mycoses 81(94.2) had CD4 counts <300 cells/μl. There was a significant association between mycoses and CD4 counts among subjects (χ2=121.4, p=0.00).

Haematological disorders Mycoses positive subjects (%) (n=86) Mycoses negative subjects (n=186) p-value Total(n=272)
Anaemia 50(58.1) 79(42.5) χ2=7.09, p=0.1 129(47.4)
Leucopenia 13(15.1) 15(8.1) χ2= 6.17, p=0.2 28(10.3)
Neutropenia 8(9.3) 34(18.3) χ2=3.5, p=0.3 42(15.4)
Lymphopenia 39(45.3) 25(13.4) χ2=33.2, p=0.00 64(23.5)
Thrombocytopenia 1(1.2) 0(0.0) χ2=3.9, p=0.6 1(0.4)
CD4 count < 300 cells/µl 81(94.2) 60(32.3) χ2=121.4, p=0.00 141(51.8)

Table 3: Distribution of haematological abnormalities among Mycoses positive and negative patients.

Table 4 summarizes the results of haematologic parameters evaluated in 272 HIV infected subjects with and without mycoses. Using Packed Cell Volume (PCV) less than 30% as an indicator of anaemia, mycoses positive patients were at a higher risk of having reduced PCV than the mycoses negative patients. The calculated mean PCV (31.6 ± 9.6) of patients with mycoses were significantly lower than those without mycoses (33.1 ± 10.4) (p=0.03). The calculated mean haemoglobin (10.4 ± 3.2 g/dl) in mycoses positive patients were significantly lower compared to the mycoses negative patients (10.9 ± 3.5) (p=0.05). Mean Corpuscular Haemoglobin Concentration (MCHC) showed no statistically significant relationship between the mycoses (31.02 ± 7.93) positive and negative (30.8 ± 7.9) patients (p= 0.8) (Table 4).

Parameters Patients with Mycoses (mean ± SD) (n=86) Patients without Mycoses (mean ± SD) (n=186) P value Level of significance
AGE (years) 33.6 ± 10.6 35.2 ± 11.5 0.2 NS
Hb (g/dl) 10.4 ± 3.2 10.9 ± 3.5 0.05 S
PCV (%) 31.6 ± 9.6 33.1 ± 10.4 0.03 S
MCHC (%) 31.02 ± 7.93 30.8 ± 7.9 0.8 NS
TWBC x103/µl) 4.51 ± 2.13 5.24 ± 2.16 0.03 S
Platelets (x103/µl) 215.9 ± 99.4 220.2 ± 98.6 0.7 NS
Eosinophils (%) 8.3 ± 7.2 7.3 ± 5.7 0.25 NS
Neutrophils (%) 50.2 ± 20.1 42.4 ± 17.8 0.001 S
Lymphocytes (%) 28.9 ± 13.9 38.9 ± 15.0 0.00 S
CD4count (cells/µl) 142.3 ± 100.1 435.5 ± 249.1 0.00 S

S–Significant
NS–Not significant

Table 4: Comparison of haematologic parameters between HIV infected subjects with and without Mycoses.

Using a total white blood cell count of (<2000 cells/μl), a lymphocyte count of (<30%), a neutrophil count of (<40%) and a platelet count of (<100×103/μl), as indicators of leucopenia, lymphopenia, neutropenia and thrombocytopenia respectively. There was a significant difference in the relative risk of developing leucopenia in the two groups, the mean total white cell counts (4.51 ± 2.13) in patients with mycoses were significantly lower when compared to their mycoses negative counterparts (5.24 ± 2.16) (p=0.03). The relative risk of developing neutropenia is higher among the mycoses negative patients (42.4 ± 17.8) when compared with their positive counterparts (50.2 ± 20.1) (0.001). There was no significant difference in the relative risk of developing thrombocytopenia in the two groups (p=0.7). On the other hand the relative risk of developing lymphopenia was significantly higher among the mycoses positive patients (28.9 ± 13.9) than the mycoses negative (28.9 ± 13.9) patients (p=0.00). The CD4 counts of the mycoses positive patients were markedly reduced (142.3 ± 100.1) when compared to the mycoses negative patients (435.5 ± 249.1) (p=0.00) (Table 4).

Various fungal infections were compared with the mean CD4 counts in these patients and there was a good association between them (Figure 1). All subjects infected with fungal pathogens had CD4 counts below 200 cells/μl of blood. Cryptococcus neoformans, Candida tropicalis, Absidia corymbifera and Candida guilliermondii were associated with CD4 counts <100 cells/μl of blood.

tropical-medicine-surgery-opportunistic-fungal-infections

Figure 1: Association of opportunistic fungal infections with the CD4 counts of Mycoses positive subjects.

Discussion

Hematological abnormalities are a common complication of HIV infection. These involve all lineages of blood cells [1]. These abnormalities increase as the disease advances [23]. The most common haematological abnormality seen in our study was anaemia. It was more prevalent among HIV positive subjects with mycoses 50 (18.3%) than the mycoses negative 79 (29.0%) subjects. The 18.3% and 29.0% prevalence among these subjects are lower than the 65% reported by Wadhwa et al. [22] in India. This may be due to the effective monitoring and treatment of HIV patients in Calabar by agencies and Government. HIV infection may lead to anaemia in many ways; the important causes include: opportunistic infections, administration of chemotherapy agents, vitamin B12 deficiency and defective iron metabolism and reutilization [24,25]. These factors were however not investigated in our study.

Anaemia was more prevalent in females 32 (37.2%) than males 18(20.9%) in mycoses positive subjects, but there was no relationship between mycoses, anaemia and gender (p=0.31). This suggests that anaemia may have resulted from other factors and not mycoses. The higher prevalence of anaemia among females suggests that they have a higher risk of developing anaemia compared to their male counterparts. Levine et al. [24] made a similar observation in their study and attributed it to sex and race whereas Volberding et al. [9] attributed it to menstrual blood loss in women and to the drains on iron stores that occur with pregnancy and delivery. The present study did not investigate the causes of anaemia among the subjects.

Leucopenia and neutropenia were noted in 28 (10.3%) and 42 (15.4%) of the patients respectively. The leucopenic status was similar to the (11.6%) reported by Wadhawa et al. [22] but neutropenia was higher than the 5 (8.3%) reported by them. Leucopenia 34 (18.3%) and neutropenia 15(8.1%) were more prevalent among mycoses negative subjects with no significant relationship with mycoses (p>0.05). This suggests that these haematological disorders could have been caused by other factors other than mycoses.

On the other hand lymphopenia was more prevalent among the mycoses positive subjects 39 (45.3%) than their negative counterparts 25 (13.4%) with a significant relationship between them (p=0.00). The 64 (23.5%) of lymphopenia reported amongst our subjects is similar to the 23.3% reported in Vellore by Kaur et al. [26]. The depletion of lymphocytes primarily of the CD4 cells subset, subsequent to cellular CD4 immunodeficiency has been noted as the hallmark of HIV infection [27]. This strongly suggests that mycoses may further deplete CD4 cells among the subjects.

Thrombocytopenia is known to be a frequent complication of HIV infection [1]. There was no statistically significant difference in the platelet counts amongst the two study groups in our cohort (p=0.6). Although the relative risk of developing thrombocytopenia in all the study populations was the same, the mean platelet counts of patients with mycoses were lower than those without mycoses.

All individuals infected with a fungal pathogen had a CD4 count <200 cells/μl of blood. This suggests that immune supression and haematological dyscrasias promote respiratory mycoses.

Total White Cell Count (TWBC), haemoglobin (Hb), PCV and lymphocytes have been reported as good predictors of CD4 counts [28], and as such may serve as useful tools in the monitoring and management of HIV patients in resource poor settings considering the fact that they are easier and cheaper to perform than techniques for assaying CD4 counts and viral load.

For further research purposes, molecular methods should be employed for the diagnosis of respiratory mycoses as microscopy and culture is insufficient for these purposes.

Conclusion

Anaemia and lymphopenia in HIV patients can be considered as good clinical indicators of underlying immune status. In view of the progressive increases of HIV in our population and the high prevalence of haematological disorders among HIV patients with respiratory infections, it is strongly recommended that all patients with respiratory infections be investigated for mycoses alongside haematological disorders as subjects with mycoses are more likely to develop haematological abnormalities like anaemia, neutropenia and lymphopenia. This suggests that respiratory mycoses may affect haematological parameters of patients especially the lymphocytes and CD4 counts. Pulmonary mycoses are leading causes of morbidity and mortality among adult HIV/AIDS patients as found in this study, but remain an under-diagnosed problem in resource-limited settings. This study presents preliminary data regarding hematological manifestations among HIV infected individuals with respiratory mycoses in Calabar, Nigeria.

References

  1. Kirchhoff F, Silvestri G (2008) Is Nef the elusive cause of HIV-associated hematopoietic dysfunction? J Clin Invest 118: 1622-1625.
  2. Okolie MN, Eghafona NO, Omoregie R (2003) Anti-human immunodeficiency virus agents. Journal of Medical Laboratory Science 12: 1-14.
  3. Aluyi HSA, Otajevwo FD, Iweriebor O (2010) Incidence of pulmonary mycoses in patients with acquired immunodeficiency diseases. Nigerian J Clin Pract 13: 78-83.
  4. Chong S, Lee KS, Yi CA, Chung MJ, Kim TS, et al. (2006) Pulmonary fungal infection: imaging findings in immunocompetent and immunocompromised patients. Eur J Radiol 59: 371-383.
  5. Thomas CF Jr, Limper AH (2007) Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol 5: 298-308.
  6. Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8: 891-896.
  7. Cosby CD (2007) Hematologic disorders associated with human immunodeficiency virus and AIDS. J Infus Nurs 30: 22-32.
  8. Moyle G (2002) Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev 4: 13-20.
  9. Volberding PA, Baker KR, Levine AM (2003) Human immunodeficiency virus hematology. Hematology Am Soc Hematol Educ Program .
  10. Idigbe EO, Adewole TA, Eisen G, Kanki P, Odunukwe NN, et al. (2005) Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program. J Acquir Immune Defic Syndr 40: 65-69.
  11. Voth R, Rossol S, Gräff E, Laubenstein HP, Schröder HC, et al. (1988) Natural killer cell activity as a prognostic parameter in the progression to AIDS. J Infect Dis 157: 851-852.
  12. Forbes BA, Sahm DF, Weissfeld AS (2002) Laboratory methods in basic mycology. In Bailey and Scott’s Diagnostic Microbiology, 11th edition St Louis: Mosby 711-798.
  13. Holland SM, Gallin JI (2004) Disorders of granulocytes and Monocytes, Harrison’s Principles of Internal Medicine (18thedn), McGraw-Hill Professional, USA 351.
  14. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH 2006.
  15. World Health Organisation (2010) CD4: The bar is raised. WHO moves to raise the indicator point for the commencement of ARV treatments, and moves towards less toxic drug options? African Health, 32: 19- 22.
  16. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC (1997) The role of Microbiology laboratory in the diagnosis of infectious disease: Guidelines to practice and management, In: Pfeiffer, R. P. and Magnus, B. C. (eds.), Color atlas and text book of diagnostic microbiology, (5thedn), Lippincot Press: New York 69.
  17. Casadevall A, Perfect JR (1998) Cryptococcus neoformans. Journal of antimicrobial chemotherapy 44: 107-108.
  18. Moore GS, Jaciow DM (1979) Mycology for the clinical laboratory. Virginia: Prentice-Hall.
  19. Procop GW, Robert GD (1998) Laboratory methods in basic mycology. In: Forbes BA, Sahm DA, Weissfied AS, Bailey and Scott’s Diagnostic microbiology, (10thedn), New York: Mosby 871.
  20. Shailaja VV, Pai LA, Mathur DR, Lakshmi V (2004) Prevalence of bacterial and fungal agents causing lower respiratory tract infections in patients with human immunodeficiency virus infection. Indian J Med Microbiol 22: 28-33.
  21. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe L (2004) Cryptococcus neoformans infections in Vancouver Hospital and Health Sciences Centre (1997-2002): Epidemiology, microbiology and histopathology. J Med Microbiol 53: 935-940.
  22. Wadhwa A, Kaur R, Agarwal SK, Jain S, Bhalla P (2007) AIDS-related opportunistic mycoses seen in a tertiary care hospital in North India. J Med Microbiol 56: 1101-1106.
  23. Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R (2009) Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disord 9: 5.
  24. Levine, A M, Berhane K, Masri-Lavine L, Sanchez M, Young M, et al. (2001) Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women’s Interagency HIV Study. Journal of Acquired Immune Deficiency Syndrome 26: 28-35.
  25. Attili SVS, Singh VP, Rai M, Varma DV, Gulati A, et al. (2008) Hematological profile of HIV patients in relation to immune status - a hospital-based cohort from Varanasi, North India. Turkish Journal of Hematology, 25:13-19.
  26. Kaur A, Babu PG, Jacob M, Narasimhan C, Ganesh A, et al. (1992) Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr 5: 883-889.
  27. Gil L, Martínez G, González I, Tarinas A, Alvarez A, et al. (2003) Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 47: 217-224.
  28. Owiredu WK, Quaye L, Amidu N, Addai-Mensah O (2011) Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci 11: 2-15.
Citation: Ogba OM, Abia-Bassey LN, Epoke J, Mandor BI, Akpotuzor J, et al. (2013) Haematological Profile of HIV Infected Patients with Opportunistic Respiratory Mycoses in Relation to Immune Status–A Hospital Based Cohort from Calabar, Nigeria. Trop Med Surg 1:122.

Copyright: © 2013 Ogba OM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.